Skip to main content
/
Incyte Corporation (LON:0J9P)
London flag London · Delayed Price · Currency is GBP · Price in USD
68.74
+1.30 (1.94%)
At close: Jun 6, 2025

Incyte Revenue

Incyte had revenue of $1.05B USD in the quarter ending March 31, 2025, with 19.53% growth. This brings the company's revenue in the last twelve months to $4.41B, up 17.13% year-over-year. In the year 2024, Incyte had annual revenue of $4.24B with 14.76% growth.

Revenue (ttm)
$4.41B
Revenue Growth
+17.13%
P/S Ratio
2.92
Revenue / Employee
$1.69M
Employees
2,617
Market Cap
9.98B GBP

Revenue Chart

Created with Highcharts 11.4.8Incyte Revenue - Annual2.67B​2.67B2.99B​2.99B3.39B​3.39B3.70B​3.70B4.24B​4.24B20202021202220232024-1B2B3B4B
* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings

Incyte News

More News